Clinical Trial Update: Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating IL-1β inhibition to reduce vascular inflammation in individuals with TET2 clonal hematopoiesis; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• IL-1β inhibitor

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Vascular Inflammation, ASCVD | Phase 2 | Status: RECRUITING